Results 71 to 80 of about 6,631 (200)

Factors Associated With Hypertension in Peruvian Adults: A Nationwide Analysis of the Demographic and Family Health Survey

The Journal of Clinical Hypertension, Volume 27, Issue 10, October 2025.
ABSTRACT Hypertension is a major modifiable risk factor for cardiovascular disease and a leading cause of morbidity and mortality worldwide. This study aimed to identify factors associated with hypertension among Peruvian adults using nationally representative data from the 2023 Demographic and Family Health Survey (ENDES).
Milagros E. Gonzales‐Falcón, Gino F. Felandro‐Taco, Miguel A. Arce‐Huamani   +2 more
wiley   +1 more source

Simulating a Specialist's Treatment Experience for Hypertension Using Deep Neural Networks

The Journal of Clinical Hypertension, Volume 27, Issue 10, October 2025.
ABSTRACT Hypertension management requires precise treatment decisions that balance medication efficacy with patient‐specific factors. While clinical guidelines exist, physician decision‐making often incorporates nuanced experience that remains challenging to quantify.
Jong‐Chol Ri, Kum‐Ryong Jo, Tae‐Ok Mun   +2 more
wiley   +1 more source

Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertension.

PLoS ONE, 2011
ObjectivesMMP-9 and -12 function in tissue remodeling and may play roles in cardiovascular disease (CVD). We assessed associations of four MMP polymorphisms and three antihypertensive drugs with cardiovascular outcomes.MethodsHypertensives (n = 42,418 ...
Rikki M Tanner, Amy I Lynch, Victoria H Brophy, John H Eckfeldt, Barry R Davis, Charles E Ford, Eric Boerwinkle, Donna K Arnett   +7 more
doaj   +1 more source

Kidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trial.

, 2013
BACKGROUND: numerous reports have linked impaired kidney function to a higher risk of cardiovascular events and mortality. There are relatively few data relating to kidney function in the very elderly. METHODS: the Hypertension in the Very Elderly Trial (
Beckett, Nigel, Bulpitt, Christopher, Burch, Lisa, Fagard, Robert, Fletcher, Astrid, Li, Mengying, Narkiewicz, Krzysztof, Nitsch, Dorothea, Peters, Ruth, Poulter, Ruth, Wang, Nan   +10 more
core   +1 more source

Risk of Benign Paroxysmal Positional Vertigo Modified by Diuretics—A Population‐Level Case‐Control Study

Otolaryngology–Head and Neck Surgery, Volume 173, Issue 3, Page 613-625, September 2025.
Abstract Objective This study aims to characterize diuretic use among patients with and without benign paroxysmal positional vertigo (BPPV) using a population‐level database. Study Design A case‐control study. Setting TriNetX US Collaborative Network. Methods Subjects with ≥1 hospital visit between 2019 and 2024 were queried and stratified by age (18 ...
Marwin Li, Rebecca C. Chiffer, Hongyan Li   +2 more
wiley   +1 more source

State-of-the-art treatment of hypertension: established and new drugs [PDF]

, 2017
The treatment of essential hypertension is based essentially on the prescription of four major classes of antihypertensive drugs, i.e. blockers of the renin-angiotensin system, calcium channel blockers, diuretics and beta-blockers.
Burnier, Michel, Vuignier, Yann, Wuerzner, Gregoire   +2 more
core  

Antihypertensive treatment decreases arterial stiffness at night but not during the day. Results from the Hypertension in the Very Elderly Trial [PDF]

, 2016
The main Hypertension in the Very Elderly Trial (HYVET) demonstrated a very marked reduction in cardiovascular events by treating hypertensive participants 80 years or older with a low dose, sustained release prescription of indapamide (indapamide SR, 1 ...
Chakravarthi Rajkumar, Christopher J. Bulpitt, Craig Anderson, Elizabeth Cheek, Gosse P, Jan A. Staessen, Kum F, Nigel Beckett, O'Rourke MF, Richard Webb, Riitta Antikainen, Ruth Peters, Williams B   +12 more
core   +1 more source

Improvements in Blood Pressure Control and the Hypertension Care Continuum Over 2 Years in Urban Haiti Amidst Civil Unrest

The Journal of Clinical Hypertension, Volume 27, Issue 9, September 2025.
ABSTRACT Hypertension (HTN) is the leading cause of death worldwide, yet only 8% of individuals have controlled blood pressure (BP) in low‐ and middle‐income countries, with particular challenges in humanitarian crisis settings including Haiti. The Haiti Cardiovascular Disease Cohort, an observational population‐based cohort in Port‐au‐Prince, offers a
Miranda Metz, Rodney Sufra, Anju Ogyu, Vanessa Rouzier, Reichling St. Sauveur, Kelly Celestin, Guyrlaine Forrestal, Fabyola Preval, Mirline Jean, Suzanne Edwidge Marcelin, Auguste Sarine, Catherine Bennett, Serena Koenig, Kenneth Jamerson, Jean William Pape, Lily D. Yan, Margaret L. McNairy   +16 more
wiley   +1 more source

From collection to correction: Can serial 24‐hour urine collections demonstrate improved urinary stone parameters?

BJUI Compass, Volume 6, Issue 8, August 2025.
Abstract Objectives To determine whether serial 24‐hour urine collections from the same patient over time result in improved stone risk parameters. Patients and Methods Using a 24‐hour urinalysis database, 1832 tests from 688 patients collected over a 10‐year period were retrospectively reviewed.
Daniel Jhang, Jason Groegler, Akin S. Amasyali, Hyukje Sung, Matthew Buell, Jersey Castillo, Elizabeth A. Baldwin, Mohamed Keheila, Zhamshid Okhunov, D. Duane Baldwin   +9 more
wiley   +1 more source

Development and Validation of Stability-Indicating Method for Estimation of Chlorthalidone in Bulk and Tablets with the Use of Experimental Design in Forced Degradation Experiments

Scientifica, 2016
Chlorthalidone was subjected to various forced degradation conditions. Substantial degradation of chlorthalidone was obtained in acid, alkali, and oxidative conditions.
Sandeep Sonawane, Sneha Jadhav, Priya Rahade, Santosh Chhajed, Sanjay Kshirsagar   +4 more
doaj   +1 more source